¹ßÇ¥Çü½Ä : Æ÷½ºÅÍ(Àü½Ã)
|
Á¢¼ö¹øÈ£ - 980211 RHPX-08 |
OLFACTORY DYSFUNCTION CAUSED BY DAMAGE OF NON-NEURONAL CELLS IN
COVID-19 |
THE AIRWAY MUCUS INSTITUTE, YONSEI UNIVERSITY COLLEGE OF MEDICINE©ö, DEPARTMENT OF OTORHINOLARYNGOLOGY, YONSEI UNIVERSITY COLLEGE OF MEDICINE©÷, HUMAN MICROBIOME CENTER, YONSEI UNIVERSITY COLLEGE OF MEDICINE©ø |
JINSUN KIM,
JINSUN KIM©ö, BO-RA KIM©ö, MIN-SEOK RHA©ö©÷, HYUNG-JU CHO©ö©÷, CHANG-HOON KIM©ö©÷©ø
|
¸ñÀû: Olfactory dysfunction has been identified in patients and several
experimental animal models of COVID-19. Previous studies have
shown that
the non-neuronal cells are the primary targets for the SARS-CoV-2
in the
olfactory epithelium. However, the mechanisms underlying
olfactory
dysfunction in patients with COVID-19 are still unclear. ¹æ¹ý:We intranasally inoculated 8-week-old K18-hACE2 transgenic mice
with the
10©÷-10⁵ PFU of SARS-CoV-2 (strain hCoV19/Korea/KCDC9481/2020).
Mice
sacrificed at 2, 4, 7 and 10dpi were analyzed for changes in the
upper
and lower respiratory tracts, brain, and abdominal organs through
histology and immunohistochemistry. In addition, the olfactory
phenotype
was investigated by performing avoidance tests. °á°ú:SARS-CoV-2 infection of K18-hACE2 mice caused a dose-dependent
respiratory illness, contributing to death. Viral antigen was detected
in the olfactory epithelium, particularly in the non-neuronal cell type,
but not in the neuronal cells. We also found that the sequential
recovery of the olfactory epithelium after 7dpi by confirming the
reduction of expression level of target markers. In the avoidance test,
mice infected with SARS-CoV-2 exhibited impaired olfactory function
compared to uninfected mice. °á·Ð:In summary, SARS-CoV-2-induced anosmia is caused by damage to
non-
neuronal cells rather than olfactory sensory neurons. These
results
suggest that inflammatory microenvironment rather than direct
neuronal
damage leads to olfactory dysfunction in COVID-19. Future studies
would be required to investigate detailed mechanisms underlying
olfactory dysfunction and subsequent recovery following SARS-CoV-
2
infection. |
|